×
Featured
Want to learn more about DIA/FDA Advancing Complex Innovative Clinical Trial Designs to Efficiently Deliver Medicines to Patients? You've come to the right site!
Program Committee
-
Robert A. Beckman, MD Professor of Oncology and of Biostatistics, Bioinformatics, and Biomathematics
Georgetown University Medical Center, United States -
Fanni Natanegara, PHD Sr. Director, Global Statistical Sciences - Japan
Eli Lilly and Company, Japan -
Zoran Antonijevic, MSC Vice President, Statistical Consulting
Abond CRO Inc., United States -
Cristiana Mayer, DRSC, PHD Head of Biostatistics
Johnson & Johnson Vision, United States -
Dionne Price, PHD Deputy Director, Office of Biostatistics, OTS, CDER
FDA, United States -
Karen Lynn Price, PHD Senior Research Fellow, Statistical Innovation Center/Design Hub
Eli Lilly and Company, United States -
Pritibha Singh, MBA, MSC Principal Investigator for Doctoral Research
ETH Zurich, Switzerland -
Rui (Sammi) Tang Vice President, Global Head of Biometrics
Servier Pharmaceuticals, United States -
Amy Xia, PHD Vice President, Center for Design and Analysis
Amgen Inc., United States -
Maria Apostolaros, JD, PHARMD, MS, RPH Deputy Vice President, Science and Regulatory Advocacy
PhRMA, United States -
Yi Liu, PHD Vice President, Biometrics
Nektar Therapeutics, United States
Have an account?